Earum Pharmaceuticals Limited revised audited earnings results for the six months and year ended March 31, 2021. For the six months, the company reported revenue from operations of INR 22.328 million against INR 271.561 million a year ago. Total revenue was INR 80.885 million against INR 284.081 million a year ago. Profit for the period was INR 16.076 million or INR 2.61 per basic share against INR 9.613 million or INR 1.56 per basic share a year ago. For the year, the company reported revenue from operations of INR 410.837 million against INR 551.088 million a year ago. Total revenue was INR 500.157 million against INR 573.818 million a year ago. Profit for the period was INR 0.882 million or INR 0.14 per basic share against profit of INR 18.152 million or INR 2.94 per basic share a year ago.